BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Donner LR, Wainwright LM, Zhang F, Biegel JA. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium. Hum Pathol 2007;38:935-9. [PMID: 17376508 DOI: 10.1016/j.humpath.2006.12.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Wang YW, Song HL, Chiang CY, Song HF, Chang HY, Chu CA, Tuan YL, Tsai KH, Ou YC, Chow NH, Tsai YS. The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid features. Transl Oncol 2021;14:101175. [PMID: 34243015 DOI: 10.1016/j.tranon.2021.101175] [Reference Citation Analysis]
2 McCluggage WG, Stewart CJR. SWI/SNF-deficient malignancies of the female genital tract. Semin Diagn Pathol 2021;38:199-211. [PMID: 32978032 DOI: 10.1053/j.semdp.2020.08.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Nobusawa S, Nakata S, Yoshida Y, Yamazaki T, Ueki K, Amano K, Yamamoto J, Miyahara M, Sugai T, Nakazato Y, Hirato J, Yokoo H. Secondary INI1-deficient rhabdoid tumors of the central nervous system: analysis of four cases and literature review. Virchows Arch 2020;476:763-72. [PMID: 31707588 DOI: 10.1007/s00428-019-02686-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Jaber OI, Ashhab MA. Metastatic poorly differentiated chordoma: the eyes do not see what the mind does not know. Autops Case Rep 2019;9:e2019120. [PMID: 31641661 DOI: 10.4322/acr.2019.120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
5 Doyle LA, Hornick JL. Epithelioid and Epithelial-Like Tumors. Practical Soft Tissue Pathology: a Diagnostic Approach 2019. [DOI: 10.1016/b978-0-323-49714-5.00006-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Karantanos T, Rooper L, Kang Y, Lin CT, Wenga P, Sagorsky S, Lauring J, Kang H. Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1-Deficient Carcinoma. Oncologist 2019;24:146-50. [PMID: 30297384 DOI: 10.1634/theoncologist.2018-0279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Kolin DL, Dong F, Baltay M, Lindeman N, MacConaill L, Nucci MR, Crum CP, Howitt BE. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma. Mod Pathol 2018;31:1442-56. [PMID: 29700418 DOI: 10.1038/s41379-018-0049-z] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 20.0] [Reference Citation Analysis]
8 Berman JJ. Genetics: Clues, Not Answers, to the Mysteries of Precision Medicine. Precision Medicine and the Reinvention of Human Disease 2018. [DOI: 10.1016/b978-0-12-814393-3.00003-2] [Reference Citation Analysis]
9 Sauter JL, Graham RP, Larsen BT, Jenkins SM, Roden AC, Boland JM. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior. Mod Pathol 2017;30:1422-32. [PMID: 28643792 DOI: 10.1038/modpathol.2017.61] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 15.5] [Reference Citation Analysis]
10 Yoshida A, Kobayashi E, Kubo T, Kodaira M, Motoi T, Motoi N, Yonemori K, Ohe Y, Watanabe SI, Kawai A, Kohno T, Kishimoto H, Ichikawa H, Hiraoka N. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities. Mod Pathol 2017;30:797-809. [PMID: 28256572 DOI: 10.1038/modpathol.2017.11] [Cited by in Crossref: 105] [Cited by in F6Publishing: 110] [Article Influence: 17.5] [Reference Citation Analysis]
11 Nazari S, Zavar N, Niafar S, Malek F, Kazemi Aghdam M, Madani F, Naderi Sorki M. Extracranial Extrarenal Rhabdoid Tumor: A Case Report. Int J Cancer Manag 2017;10. [DOI: 10.5812/ijcm.9600] [Reference Citation Analysis]
12 Ramalingam P, Croce S, McCluggage WG. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology. Histopathology 2017;70:359-66. [PMID: 27656868 DOI: 10.1111/his.13091] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 8.7] [Reference Citation Analysis]
13 Wang J, Andrici J, Sioson L, Clarkson A, Sheen A, Farzin M, Toon CW, Turchini J, Gill AJ. Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency. Hum Pathol 2016;55:83-90. [PMID: 27184481 DOI: 10.1016/j.humpath.2016.04.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
14 Jamshidi F, Bashashati A, Shumansky K, Dickson B, Gokgoz N, Wunder JS, Andrulis IL, Lazar AJ, Shah SP, Huntsman DG, Nielsen TO. The genomic landscape of epithelioid sarcoma cell lines and tumours. J Pathol 2016;238:63-73. [PMID: 26365879 DOI: 10.1002/path.4636] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
15 Stewart CJ, Crook ML. SWI/SNF complex deficiency and mismatch repair protein expression in undifferentiated and dedifferentiated endometrial carcinoma. Pathology 2015;47:439-45. [DOI: 10.1097/pat.0000000000000270] [Cited by in Crossref: 70] [Cited by in F6Publishing: 73] [Article Influence: 8.8] [Reference Citation Analysis]
16 Rekhi B, Vogel U. Utility of characteristic ‘Weak to Absent’ INI1/SMARCB1/BAF47 expression in diagnosis of synovial sarcomas. APMIS 2015;123:618-28. [DOI: 10.1111/apm.12395] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
17 Strehl JD, Wachter DL, Fiedler J, Heimerl E, Beckmann MW, Hartmann A, Agaimy A. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant. Ann Diagn Pathol 2015;19:198-202. [PMID: 25920939 DOI: 10.1016/j.anndiagpath.2015.04.001] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 10.3] [Reference Citation Analysis]
18 Agaimy A, Haller F, Frohnauer J, Schaefer IM, Ströbel P, Hartmann A, Stoehr R, Klöppel G. Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes. Mod Pathol 2015;28:248-60. [PMID: 25103069 DOI: 10.1038/modpathol.2014.100] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 8.3] [Reference Citation Analysis]
19 Fung K, Yu Z, Petropoulou K. Tumors of the Central Nervous System. Pediatric Malignancies: Pathology and Imaging 2015. [DOI: 10.1007/978-1-4939-1729-7_6] [Reference Citation Analysis]
20 Agaimy A. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity. Adv Anat Pathol 2014;21:394-410. [PMID: 25299309 DOI: 10.1097/PAP.0000000000000038] [Cited by in Crossref: 115] [Cited by in F6Publishing: 118] [Article Influence: 12.8] [Reference Citation Analysis]
21 Agaimy A, Koch M, Lell M, Semrau S, Dudek W, Wachter DL, Knöll A, Iro H, Haller F, Hartmann A. SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms. Am J Surg Pathol 2014;38:1274-81. [PMID: 24832165 DOI: 10.1097/PAS.0000000000000236] [Cited by in Crossref: 109] [Cited by in F6Publishing: 111] [Article Influence: 12.1] [Reference Citation Analysis]
22 Folpe AL. Selected topics in the pathology of epithelioid soft tissue tumors. Mod Pathol 2014;27 Suppl 1:S64-79. [PMID: 24384854 DOI: 10.1038/modpathol.2013.175] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
23 Rekhi B, A. Jambhekar N. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: An experience at a Tertiary Cancer Referral Centre. Pathology - Research and Practice 2013;209:758-66. [DOI: 10.1016/j.prp.2013.08.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
24 Al-Saidi NA, Akhtar M. Sarcomatoid renal cell carcinoma with rhabdoid features. Ann Saudi Med 2013;33:495-9. [PMID: 24188946 DOI: 10.5144/0256-4947.2013.495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Pancione M, Remo A, Sabatino L, Zanella C, Votino C, Fucci A, Di Blasi A, Lepore G, Daniele B, Fenizia F, Molinari E, Normanno N, Manfrin E, Vendraminelli R, Colantuoni V. Right-sided rhabdoid colorectal tumors might be related to the serrated pathway. Diagn Pathol 2013;8:31. [PMID: 23425390 DOI: 10.1186/1746-1596-8-31] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
26 Saïji E, Guillou L, Hornick JL. Epithelioid and Epithelial-like Tumors. Practical Soft Tissue Pathology: A Diagnostic Approach 2013. [DOI: 10.1016/b978-1-4160-5455-9.00006-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Chakrapani AL, White CR, Korcheva V, White K, Lofgren S, Zonana J, Moore S, Krol A, Mansoor A. Congenital Extrarenal Malignant Rhabdoid Tumor in an Infant With Distal 22q11.2 Deletion Syndrome: The Importance of SMARCB1. The American Journal of Dermatopathology 2012;34:e77-80. [DOI: 10.1097/dad.0b013e31825793c3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
28 Kleinschmidt-demasters B, Birks DK, Aisner DL, Hankinson TC, Rosenblum MK. Atypical Teratoid/Rhabdoid Tumor Arising in a Ganglioglioma: Genetic Characterization. American Journal of Surgical Pathology 2011;35:1894-901. [DOI: 10.1097/pas.0b013e3182382a3f] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.8] [Reference Citation Analysis]
29 Kohashi K, Oda Y, Yamamoto H, Tamiya S, Matono H, Iwamoto Y, Taguchi T, Tsuneyoshi M. Reduced expression of SMARCB1/INI1 protein in synovial sarcoma. Mod Pathol 2010;23:981-90. [PMID: 20305614 DOI: 10.1038/modpathol.2010.71] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 7.5] [Reference Citation Analysis]
30 Parham DM. SMALL ROUND CELL TUMORS. Modern Soft Tissue Pathology 2010. [DOI: 10.1017/cbo9780511781049.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Tafe LJ, Garg K, Chew I, Tornos C, Soslow RA. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms. Mod Pathol 2010;23:781-9. [PMID: 20305618 DOI: 10.1038/modpathol.2010.41] [Cited by in Crossref: 188] [Cited by in F6Publishing: 189] [Article Influence: 14.5] [Reference Citation Analysis]
32 Kalpana GV, Smith ME. Development of Targeted Therapies for Rhabdoid Tumors Based on the Functions of INI1/hSNF5 Tumor Suppressor. Molecularly Targeted Therapy for Childhood Cancer 2010. [DOI: 10.1007/978-0-387-69062-9_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Kohashi K, Oda Y, Tsuneyoshi M. Authors' reply to letter to the editor: direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma. Human Pathology 2009;40:1362-1364. [DOI: 10.1016/j.humpath.2009.04.015] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Kohashi K, Oda Y, Yamamoto H, Tamiya S, Oshiro Y, Izumi T, Taguchi T, Tsuneyoshi M. SMARCB1/INI1 Protein Expression in Round Cell Soft Tissue Sarcomas Associated With Chromosomal Translocations Involving EWS: A Special Reference to SMARCB1/INI1 Negative Variant Extraskeletal Myxoid Chondrosarcoma. American Journal of Surgical Pathology 2008;32:1168-74. [DOI: 10.1097/pas.0b013e318161781a] [Cited by in Crossref: 116] [Cited by in F6Publishing: 117] [Article Influence: 7.7] [Reference Citation Analysis]
35 Soslow RA. Uterine mesenchymal tumors: a review of selected topics. Diagnostic Histopathology 2008;14:175-88. [DOI: 10.1016/j.mpdhp.2008.02.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]